-
公开(公告)号:US20230087378A1
公开(公告)日:2023-03-23
申请号:US17786996
申请日:2020-12-18
Applicant: UCB BIOPHARMA SRL
Inventor: Adnan Rahman Khan , Sam Philip Heywood , David Paul Humphreys , Daniel John Lightwood , Emma Dave , Emily Mary Cairistine Barry , Sarah Jayne Stanyon
Abstract: The present invention relates to a multi-specific antibody having specificity for human IL-13, human IL-17A and/or human IL-17F. The invention further relates to methods for producing the multi-specific antibody and to its therapeutic use for the treatment of atopic dermatitis and other diseases.
-
公开(公告)号:US20230242677A1
公开(公告)日:2023-08-03
申请号:US17787094
申请日:2020-12-18
Applicant: UCB BIOPHARMA SRL
Inventor: Emily Mary Cairistine Barry , Emma Dave , Sam Philip Heywood
CPC classification number: C07K16/468 , C07K1/22 , C12N15/63 , C07K2317/31 , C07K2317/624
Abstract: Multi-specific Antibodies The present disclosure relates to a multi-specific antibody comprising or consisting of: a) a polypeptide chain of formula (I): VH-CH1-(CH2)-(CH3)-(X)-(V1); and b) a polypeptide chain of formula (II): (V3)-(Z) -VL-CL-(Y)-(V2) wherein the polypeptide chain of formula (II) comprises at least one dsscFv, dsFv, scFv, VH or VHH, and wherein the polypeptide chain of formula (I) comprises a protein A binding domain and wherein the polypeptide chain of formula (II) does not bind protein A. The disclosure also provides polynucleotide sequences encoding said multi-specific antibody, vectors comprising the polynucleotides and host cells comprising said vectors and/or polynucleotide sequences. The disclosure also provides pharmaceutical formulations comprising same, for example for use in treatment. There is also provided a method of expressing a multi-specific antibody of the present disclosure from a host cell.
-